Loading...
Loading...
Analysts at Piper Jaffray upgraded
CryoLife Inc.CRY from Neutral to Overweight.
The price target for CryoLife has been raised from $10 to $15.
CryoLife shares have dropped 5.20% over the past 52 weeks, while the S&P 500 index has gained 13.38% in the same period.
CryoLife's shares rose 1.07% to close at $10.39 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in